Celularity Inc.(CELU)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CELU Celularity Inc.

未开盘 04-15 16:00:00 EDT

1.25

-0.05

-3.85%

盘后1.30

+0.05+3.86%

16:47 EDT

最高1.30	最低1.24	成交量5,835
今开1.25	昨收1.30	日振幅4.61%
总市值3,605万	流通市值2,015万	总股本2,884万
成交额7,390	换手率0.04%	流通股本1,612万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CELU","market":"US","secType":"STK","nameCN":"Celularity Inc.","latestPrice":1.25,"timestamp":1776283200000,"preClose":1.3,"halted":0,"volume":5835,"hourTrading":{"tag":"盘后","latestPrice":1.2982,"preClose":1.25,"latestTime":"16:47 EDT","volume":144,"amount":185.9696,"timestamp":1776286071756,"change":0.0482,"changeRate":0.03856,"amplitude":0.03856},"delay":0,"changeRate":-0.03846153846153849,"floatShares":16123000,"shares":28837800,"eps":-3.352179,"marketStatus":"未开盘","change":-0.05,"latestTime":"04-15 16:00:00 EDT","open":1.2526,"high":1.3,"low":1.2401,"amount":7390.2778215,"amplitude":0.046077,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.352179,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1776326400000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":1.3,"postHourTrading":{"tag":"盘后","latestPrice":1.2982,"preClose":1.25,"latestTime":"16:47 EDT","volume":144,"amount":185.9696,"timestamp":1776286071756,"change":0.0482,"changeRate":0.03856,"amplitude":0.03856},"volumeRatio":0.426604,"impliedVol":1.2271,"impliedVolPercentile":0.6908},"requestUrl":"/m/hq/s/CELU","defaultTab":"news","newsList":[{"id":"1106679764","title":"Nexgel披露授权与收购商业化阶段再生生物材料产品组合协议的具体条款","url":"https://stock-news.laohu8.com/highlight/detail?id=1106679764","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106679764?lang=zh_cn&edition=full","pubTime":"2026-03-12 21:06","pubTimestamp":1773320791,"startTime":"0","endTime":"0","summary":"Nexgel公司已公布其授权并收购一系列商业化阶段再生生物材料产品组合的协议考量条款。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXGL","CELU","NXGLW","BK4198","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134454050","title":"Nexgel达成协议 预计年收入将翻三倍至3500万美元并实现盈利","url":"https://stock-news.laohu8.com/highlight/detail?id=1134454050","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134454050?lang=zh_cn&edition=full","pubTime":"2026-03-12 21:06","pubTimestamp":1773320783,"startTime":"0","endTime":"0","summary":"Nexgel公司近日宣布达成一项具有里程碑意义的合作协议。该交易预计将使公司年收入实现三倍增长，达到3500万美元规模，并在交易完成后立即推动公司实现盈利目标。\n这项战略性合作将显著提升Nexgel在凝胶材料领域的市场地位。收入的大幅增长将为企业带来充足的现金流，为后续的研发投入和市场扩张提供有力支撑。分析指出，此次合作不仅能够快速改善公司的财务状况，还将为长期可持续发展奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELU","BK4198","BK4139","NXGL","NXGLW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141502892","title":"Celularity重申与Nexgel战略商业化合作 聚焦开发生物材料产品线并拓展510(K)通道新机遇","url":"https://stock-news.laohu8.com/highlight/detail?id=1141502892","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141502892?lang=zh_cn&edition=full","pubTime":"2026-03-12 20:32","pubTimestamp":1773318773,"startTime":"0","endTime":"0","summary":"生物技术公司Celularity Inc.近日重申与NEXGEL, INC.达成的战略商业化合作。该合作将依托双方现有商业化产品体系，共同构建生物材料领域的产品矩阵，同时积极开拓通过510监管通道的新产品机会。此次合作将整合Celularity在细胞疗法领域的创新技术与Nexgel的水凝胶材料平台优势，旨在加速创伤修复、组织再生等医疗场景的生物材料解决方案落地。合作双方表示，这一战略伙伴关系将强化其在生物材料市场的竞争力，为医疗行业提供更全面的产品组合。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELU","NXGL","BK4198","CELUW","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111760684","title":"Nexgel签署最终协议 获授权并收购商业化阶段再生生物材料产品组合","url":"https://stock-news.laohu8.com/highlight/detail?id=1111760684","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111760684?lang=zh_cn&edition=full","pubTime":"2026-03-10 20:45","pubTimestamp":1773146715,"startTime":"0","endTime":"0","summary":"Nexgel公司已正式签署具有约束力的最终协议，将授权并收购一系列处于商业化阶段的革命性再生生物材料产品组合。该交易标志着公司正式进军高增长潜力的再生医学领域，通过整合成熟技术平台与现有产品线形成协同效应。此次收购的产品组合包含多款经临床验证的生物材料，可广泛应用于创伤修复、组织工程等医疗场景。协议执行后，Nexgel将获得相关产品的全球商业化权利及生产技术，预计将显著增强其在高端医疗器械市场的竞争力。此次战略布局有望为公司开辟新的收入来源，并推动其向综合性生物医学解决方案提供商转型。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NXGL","NXGLW","CELU","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104849797","title":"Celularity签署3500万美元战略许可协议，巩固资本实力推进长寿战略","url":"https://stock-news.laohu8.com/highlight/detail?id=1104849797","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104849797?lang=zh_cn&edition=full","pubTime":"2026-03-10 20:31","pubTimestamp":1773145912,"startTime":"0","endTime":"0","summary":"生物科技公司Celularity Inc.（纳斯达克代码：CELU）近日达成一项总额3500万美元的战略性许可协议。该交易显著增强了公司的资本状况，为其专注于延长人类健康寿命的核心战略提供了强有力的资金支持。此次合作不仅为Celularity带来了可观的非稀释性资金，更将加速其基于胎盘源性干细胞技术的创新疗法研发进程，标志着公司在实现其“长寿战略”的征途上迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELUW","CELU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120331482","title":"Celularity Inc. 将生物材料业务相关人员转移至商业合作伙伴；并宣布进一步裁员","url":"https://stock-news.laohu8.com/highlight/detail?id=1120331482","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120331482?lang=zh_cn&edition=full","pubTime":"2026-03-10 20:31","pubTimestamp":1773145911,"startTime":"0","endTime":"0","summary":"生物技术公司Celularity Inc.近日宣布了一项重要人事调整。公司决定，将与其生物材料业务活动相关的员工团队，整体转移至一家商业合作伙伴处。这一举措旨在优化公司资源配置，聚焦核心研发领域。\n与此同时，Celularity Inc. 还宣布了进一步的裁员计划。这是公司为提升运营效率、实现长期战略目标而采取的结构性调整的一部分。此次人员变动预计将使公司的组织架构更为精简高效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CELU","CELUW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130950545","title":"Celularity Inc. 组织架构重组降低运营开支，聚焦长寿疗法领域","url":"https://stock-news.laohu8.com/highlight/detail?id=1130950545","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130950545?lang=zh_cn&edition=full","pubTime":"2026-03-10 20:31","pubTimestamp":1773145874,"startTime":"0","endTime":"0","summary":"生物技术公司Celularity Inc.近期宣布了一项重要的组织架构重组计划。此举旨在通过优化内部结构，显著降低公司的运营成本。\n重组后的Celularity将更专注于其核心战略方向——长寿疗法的研发。这一调整预示着公司资源将更集中地投入到具有巨大潜力的抗衰老治疗领域，以推动其长期增长目标。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CELU","CELUW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609734236","title":"Celularity Inc.盘中异动 下午盘快速拉升5.28%报1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609734236","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609734236?lang=zh_cn&edition=full","pubTime":"2026-02-05 02:37","pubTimestamp":1770230257,"startTime":"0","endTime":"0","summary":"北京时间2026年02月05日02时37分，Celularity Inc.股票出现异动，股价急速拉升5.28%。截至发稿，该股报1.30美元/股，成交量1.8982万股，换手率0.07%，振幅4.88%。Celularity Inc.股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，Veradermics, Incorporated、Abpro Holdings Inc C/Wts 12/11/2029 、Celularity Inc C/Wts 16/07/2026 涨幅较大，Biodexa Pharmaceuticals Plc、Liminatus Pharma, Inc.、Gri Bio, Inc.较为活跃，换手率分别为421.48%、259.47%、213.21%，振幅较大的相关个股有Liminatus Pharma, Inc.、Celularity Inc C/Wts 16/07/2026 、Veradermics, Incorporated，振幅分别为94.39%、61.25%、46.71%。该公司的大部分收入来自临床级生物样本库部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205023737953fda6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205023737953fda6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CELU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605438357","title":"Celularity Inc.盘中异动 下午盘股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605438357","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605438357?lang=zh_cn&edition=full","pubTime":"2026-01-22 04:27","pubTimestamp":1769027235,"startTime":"0","endTime":"0","summary":"北京时间2026年01月22日04时27分，Celularity Inc.股票出现异动，股价大幅跳水5.30%。截至发稿，该股报1.25美元/股，成交量5571股，换手率0.02%，振幅6.06%。Celularity Inc.股票所在的生物技术行业中，整体涨幅为1.52%。Celularity Inc.公司简介：Celularity Inc 是一家临床阶段的生物技术公司，开发现成的胎盘来源的异体细胞疗法，包括转基因和未修饰的NK细胞，工程T细胞和间充质样粘附基质细胞，针对癌症，免疫，感染性和退行性疾病的适应症。该公司的大部分收入来自临床级生物样本库部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012204271597a2d2e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012204271597a2d2e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CELU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586286878","title":"Celularity Inc.盘中异动 早盘股价大涨6.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586286878","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586286878?lang=zh_cn&edition=full","pubTime":"2025-11-25 22:45","pubTimestamp":1764081901,"startTime":"0","endTime":"0","summary":"北京时间2025年11月25日22时45分，Celularity Inc.股票出现异动，股价大幅上涨6.49%。Celularity Inc.股票所在的生物技术行业中，整体涨幅为0.74%。Celularity Inc.公司简介：Celularity Inc 是一家临床阶段的生物技术公司，开发现成的胎盘来源的异体细胞疗法，包括转基因和未修饰的NK细胞，工程T细胞和间充质样粘附基质细胞，针对癌症，免疫，感染性和退行性疾病的适应症。该公司的大部分收入来自临床级生物样本库部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125224501a710dfd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125224501a710dfd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CELU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584184169","title":"Celularity Inc.盘中异动 股价大涨5.26%报1.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584184169","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584184169?lang=zh_cn&edition=full","pubTime":"2025-11-19 02:09","pubTimestamp":1763489371,"startTime":"0","endTime":"0","summary":"北京时间2025年11月19日02时09分，Celularity Inc.股票出现异动，股价急速上涨5.26%。截至发稿，该股报1.60美元/股，成交量2.0705万股，换手率0.07%，振幅5.41%。Celularity Inc.股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，Olema Pharmaceuticals, Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 、Arvinas, Inc.涨幅较大，Can Fite Biopharma Ltd、Clearmind Medicine Inc.、Aspire Biopharma Holdings, Inc.较为活跃，换手率分别为1974.71%、1151.15%、442.79%，振幅较大的相关个股有Olema Pharmaceuticals, Inc.、Clearmind Medicine Inc.、Can Fite Biopharma Ltd，振幅分别为106.34%、63.78%、61.69%。该公司的大部分收入来自临床级生物样本库部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119020931a702753e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119020931a702753e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CELU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518224083","title":"Celularity Inc.盘中异动 股价大跌5.69%报1.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518224083","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518224083?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:37","pubTimestamp":1741613842,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时37分，Celularity Inc.股票出现异动，股价快速下跌5.69%。截至发稿，该股报1.16美元/股，成交量8.9397万股，换手率0.38%，振幅6.26%。Celularity Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Scisparc Ltd.、Dogwood Therapeutics, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为459.93%、68.40%、50.95%，振幅较大的相关个股有珐博进、Seer, Inc.、Scisparc Ltd.，振幅分别为98.92%、98.72%、32.29%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021372298a29e3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021372298a29e3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CELU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517655931","title":"Celularity Inc.盘中异动 早盘大幅跳水5.05%报1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517655931","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517655931?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:36","pubTimestamp":1741271769,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时36分，Celularity Inc.股票出现异动，股价急速下跌5.05%。截至发稿，该股报1.30美元/股，成交量2.4596万股，换手率0.10%，振幅2.92%。Celularity Inc.股票所在的生物技术行业中，整体跌幅为0.52%。其相关个股中，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1027.16%、163.48%、52.81%，振幅较大的相关个股有Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ，振幅分别为24.20%、23.83%、23.12%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223609989eb544&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223609989eb544&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CELU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517291009","title":"Celularity Inc.股价拉升11.11% 市值涨317.4万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517291009","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517291009?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:30","pubTimestamp":1741185007,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时30分，Celularity Inc.股票出现波动，股价快速上涨11.11%。截至发稿，该股报1.20美元/股，成交量3913股，换手率0.02%，振幅0.00%。Celularity Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Opthea Limited、Celularity Inc.、Radiopharm Theranostics Limited涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Zyversa Therapeutics, Inc.较为活跃，换手率分别为308.18%、248.66%、170.91%，振幅较大的相关个股有Zura Bio Limited、Novabay Pharmaceuticals, Inc.、Kairos Pharma, Ltd.，振幅分别为5.61%、4.37%、2.73%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223007abe9b013&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223007abe9b013&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CELU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516720476","title":"Celularity Inc.盘中异动 股价大跌5.98%报1.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516720476","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516720476?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:33","pubTimestamp":1741098797,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时33分，Celularity Inc.股票出现波动，股价急速下跌5.98%。截至发稿，该股报1.10美元/股，成交量1565股，换手率0.01%，振幅2.14%。Celularity Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Exicure, Inc.涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1057.48%、1056.48%、416.50%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Adma Biologics Inc、Ibio, Inc.，振幅分别为23.30%、12.57%、11.23%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223317989bac75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223317989bac75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CELU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516634999","title":"Celularity Inc.盘中异动 早盘急速上涨5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634999","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634999?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:37","pubTimestamp":1741012644,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时37分，Celularity Inc.股票出现波动，股价急速上涨5.60%。截至发稿，该股报1.23美元/股，成交量2.3851万股，换手率0.10%，振幅6.47%。Celularity Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Geovax Labs, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为48.51%、33.20%、31.61%，振幅较大的相关个股有Entero Therapeutics Inc.、Pliant Therapeutics, Inc.、Spruce Biosciences, Inc.，振幅分别为21.22%、19.85%、19.25%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223724a25d41ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223724a25d41ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CELU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514335078","title":"Celularity Inc.盘中异动 股价大跌5.11%报1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514335078","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514335078?lang=zh_cn&edition=full","pubTime":"2025-02-28 02:10","pubTimestamp":1740679827,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日02时10分，Celularity Inc.股票出现异动，股价急速下挫5.11%。截至发稿，该股报1.30美元/股，成交量13.0836万股，换手率0.55%，振幅6.94%。Celularity Inc.股票所在的生物技术行业中，整体涨幅为0.24%。Celularity Inc.公司简介：Celularity Inc 是一家临床阶段的生物技术公司，致力于开发现成的胎盘衍生同种异体细胞疗法、工程化 T 细胞和间充质样粘附基质细胞，针对癌症、免疫、传染病和退行性疾病等适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228021027a256ad18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228021027a256ad18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CELU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514862250","title":"Celularity Inc.盘中异动 临近收盘急速下跌5.52%报1.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514862250","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514862250?lang=zh_cn&edition=full","pubTime":"2025-02-27 04:33","pubTimestamp":1740602028,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日04时33分，Celularity Inc.股票出现波动，股价急速下挫5.52%。截至发稿，该股报1.37美元/股，成交量14.6218万股，换手率0.61%，振幅7.63%。Celularity Inc.股票所在的生物技术行业中，整体跌幅为0.71%。Celularity Inc.公司简介：Celularity Inc 是一家临床阶段的生物技术公司，致力于开发现成的胎盘衍生同种异体细胞疗法、工程化 T 细胞和间充质样粘附基质细胞，针对癌症、免疫、传染病和退行性疾病等适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270433489893ebc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270433489893ebc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CELU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514013055","title":"Celularity Inc.盘中异动 早盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514013055","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514013055?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:08","pubTimestamp":1740496091,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时08分，Celularity Inc.股票出现异动，股价大幅跳水5.00%。截至发稿，该股报1.52美元/股，成交量4.5552万股，换手率0.19%，振幅7.50%。Celularity Inc.股票所在的生物技术行业中，整体涨幅为0.84%。Celularity Inc.公司简介：Celularity Inc 是一家临床阶段的生物技术公司，致力于开发现成的胎盘衍生同种异体细胞疗法、工程化 T 细胞和间充质样粘附基质细胞，针对癌症、免疫、传染病和退行性疾病等适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225230812962ffb1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225230812962ffb1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CELU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513208937","title":"Celularity Inc.盘中异动 大幅跳水5.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513208937","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513208937?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:03","pubTimestamp":1740409427,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时03分，Celularity Inc.股票出现波动，股价快速下挫5.95%。截至发稿，该股报1.58美元/股，成交量4.629万股，换手率0.19%，振幅5.95%。Celularity Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Pepgen Inc.、Avalo Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为157.72%、70.42%、25.66%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、41.14%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230347962ea0ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230347962ea0ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CELU"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.celularity.com","stockEarnings":[{"period":"1week","weight":-0.0876},{"period":"1month","weight":0.0081},{"period":"3month","weight":-0.031},{"period":"6month","weight":-0.3687},{"period":"1year","weight":-0.2816},{"period":"ytd","weight":0.1261}],"compareEarnings":[{"period":"1week","weight":0.0354},{"period":"1month","weight":0.0462},{"period":"3month","weight":0.0111},{"period":"6month","weight":0.0535},{"period":"1year","weight":0.3019},{"period":"ytd","weight":0.0264}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Celularity Inc.根据特拉华州法律于2016年8月29日成立。Cellarity是一家临床阶段的生物技术公司，通过开发现成的胎盘源性异基因T细胞，利用嵌合抗原受体细胞、自然杀伤细胞（“NK”）细胞和间充质样粘附基质细胞（“ASCs”）进行工程化，针对癌症，传染病和退行性疾病，引领细胞医学的下一个发展方向。Cellarity相信，通过利用胎盘独特的生物学特性和现成的可用性，它将能够开发出治疗解决方案，以满足全球对有效、易获得和负担得起的治疗方法的重大需求。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.012575},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.011645},{"month":3,"riseRate":0.571429,"avgChangeRate":0.16045},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.044257},{"month":5,"riseRate":0.666667,"avgChangeRate":0.086371},{"month":6,"riseRate":0.5,"avgChangeRate":-0.159828},{"month":7,"riseRate":0.333333,"avgChangeRate":0.031304},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.023952},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.157824},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.097694},{"month":11,"riseRate":0.571429,"avgChangeRate":0.028019},{"month":12,"riseRate":0.571429,"avgChangeRate":-0.094117}],"exchange":"NASDAQ","name":"Celularity Inc.","nameEN":"Celularity Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.41.0","shortVersion":"4.41.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Celularity Inc.(CELU)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Celularity Inc.(CELU)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Celularity Inc.,CELU,Celularity Inc.股票,Celularity Inc.股票老虎,Celularity Inc.股票老虎国际,Celularity Inc.行情,Celularity Inc.股票行情,Celularity Inc.股价,Celularity Inc.股市,Celularity Inc.股票价格,Celularity Inc.股票交易,Celularity Inc.股票购买,Celularity Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Celularity Inc.(CELU)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Celularity Inc.(CELU)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}